New Pill Successfully Lowers Lp(a) Levels

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk and for which no approved therapies currently exist.
Medscape Medical News

source https://www.medscape.com/viewarticle/new-pill-successfully-lowers-lp-levels-2024a1000l13?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost